BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9861274)

  • 1. Mectizan delivery systems and cost recovery in the Central African Republic.
    Hopkins AD
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S97-100. PubMed ID: 9861274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery systems and cost recovery in Mectizan treatment for onchocerciasis.
    Amazigo U; Noma M; Boatin BA; Etya'alé DE; Sékétéli A; Dadzie KY
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S23-31. PubMed ID: 9861264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mectizan Donation Program (MDP).
    Thylefors B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():39-44. PubMed ID: 18718154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Mectizan Donation Program: 20 years of successful collaboration - a retrospective.
    Colatrella B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():7-11. PubMed ID: 18718147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cameroon and Chad: cost recovery.
    Godin C
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S163-4. PubMed ID: 9861286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
    Etya'alé DE
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The delivery of ivermectin (Mectizan).
    Burnham G; Mebrahtu T
    Trop Med Int Health; 2004 Apr; 9(4):A26-44. PubMed ID: 15078277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
    Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
    Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onchocercal eye disease and the impact of Mectizan treatment.
    Abiose A
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S11-22. PubMed ID: 9861263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of establishing community-directed treatment with Mectizan in Uganda.
    Okwero P
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S171-4. PubMed ID: 9861290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method to determine the coverage of ivermectin distribution in onchocerciasis-control programmes.
    Schwartz EC; Renk J; Hopkins AD; Huss R; Foster A
    Ann Trop Med Parasitol; 1998 Oct; 92(7):793-6. PubMed ID: 9924537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mectizan Donation Programme--a 10-year report.
    Dull HB; Meredith SE
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S69-71. PubMed ID: 9861270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The World Bank.
    Bangoura O
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():31-3. PubMed ID: 18718152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems and perspectives of managing an onchocerciasis control programme: a case study from Plateau state, Nigeria.
    Miri ES
    Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S121-8. PubMed ID: 9861277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mectizan(®) procurement and delivery for onchocerciasis mass drug administration programmes.
    Ogoussan KT; Hopkins A
    Acta Trop; 2011 Sep; 120 Suppl 1():S173-6. PubMed ID: 20974105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operational lessons from 20 years of the Mectizan Donation Program for the control of onchocerciasis.
    Thylefors B; Alleman MM; Twum-Danso NA
    Trop Med Int Health; 2008 May; 13(5):689-96. PubMed ID: 18419585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
    Duamor CT; Datchoua-Poutcheu FR; Chounna Ndongmo WP; Yoah AT; Njukang E; Kah E; Maingeh MS; Kengne-Ouaffo JA; Tayong DB; Enyong PA; Wanji S
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0005966. PubMed ID: 29155826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community financing of local ivermectin distribution in Nigeria: potential payment and cost-recovery outlook.
    Onwujekwe OE; Shu EN; Okonkwo PO
    Trop Doct; 2000 Apr; 30(2):91-4. PubMed ID: 10842555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The community-directed, ivermectin-treatment programme for onchocerciasis control in Uganda--an evaluative study (1993-1997).
    Katabarwa M; Mutabazi D; Richards F
    Ann Trop Med Parasitol; 1999 Oct; 93(7):727-35. PubMed ID: 10715701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DISTRIBUTION AND UTILISATION OF IVERMECTIN (MECTIZAN): A CHEMOTHERAPEUTIC APPROACH TO THE CONTROL OF ONCHOCERCIASIS IN OLD OHAOZARA LGA, EBONYI STATE, EASTERN NIGERIA.
    Okpara EM; Mnaemeka AM; Iyioku UU; Udoh UV
    J Egypt Soc Parasitol; 2015 Dec; 45(3):663-70. PubMed ID: 26939245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.